Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03310476 · ClinicalTrials.gov registry record · NA

Influence of Resistant Starch Intake in Potatoes on Blood Glucose and Satiety Responses in Overweight Females

A NA study, sponsored by Texas Woman's University.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT03310476: Completed NA study, sponsored by Texas Woman's University.

NCT03310476 is a NA study that has completed, run by Texas Woman's University. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03310476, a NA study, has completed, sponsored by Texas Woman's University.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

Resistant starch (RS) is a type of fiber that has unique digestive properties that can impact overall health including glucose homeostasis and satiety. RS found in potatoes can be increased by using certain cooking methods and serving temperatures. The purpose of this trial will compare the acute glycemic and satiety responses after consuming potatoes differing in RS content that are 1) baked then chilled or 2) boiled and consumed hot in overweight females on two separate occasions.

Primary Outcome

Postprandial glucose and insulin concentrations will be compared between interventions

Interventions

  • OTHER Potatoes

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2018-01-01
Est. Completion 2019-08-31
Phase NA
Texas Woman's University

51 total trials

What the finished NCT03310476 record still lists

NCT03310476 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Potatoes is the first listed.

NCT03310476 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03310476 about?

NCT03310476 is a clinical study titled "Influence of Resistant Starch Intake in Potatoes on Blood Glucose and Satiety Responses in Overweight Females". Resistant starch (RS) is a type of fiber that has unique digestive properties that can impact overall health including glucose homeostasis and satiety. RS found in potatoes can be increased by using certain cooking methods and serving temperatures. The purpose of this trial will compare the acute gl...

What is the current status of trial NCT03310476?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2018-01-01. Estimated completion is 2019-08-31.

What interventions are being tested in trial NCT03310476?

The interventions under investigation include: Potatoes (OTHER).

Who is sponsoring clinical trial NCT03310476?

This trial is sponsored by Texas Woman's University, which has 51 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03310476's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03310476, the US trial registry maintained by the National Library of Medicine. NCT03310476 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.